Palvella Therapeutics, Inc. (PVLA) NASDAQ
122.06
-14.54(-10.64%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 26.71M |
| Enterprise Value | -56.89M |
| P/E Ratio | -45.34 |
| PEG Ratio | -2.97 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 38.62 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -81.14 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.49 |
| Return On Equity | -0.64 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.12M |
| Net Income | -17.43M |
| Diluted EPS | -7.83 |
Balance Sheet
| Total Cash | 63.57M |
| Total Cash/Share | 5.75 |
| Total Debt | 16.02M |
| Total Debt/Equity | 0.41 |
| Current Ratio | 6.49 |
| Book Value Per Share | 3.5 |
Price History
| 52-Week Change | 396.76 |
| 52-Week High | 151.18 |
| 52-Week Low | 18.23 |
| Moving Average 50 Days | 100.78 |
| Moving Average 200 Days | 68.57 |
Statistics
| Average Volume | 327,036 |
| Shares Outstanding | 11.84M |
| % Held by Institutions | 88.21 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
| Last Split Date | April 23, 2024 |
